- Home
- BSY vs NBIX Comparison
BSY vs NBIX Comparison
Compare BSY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSY
- NBIX
- Stock Information
- Founded
- BSY 1984
- NBIX 1992
- Country
- BSY United States
- NBIX United States
- Employees
- BSY N/A
- NBIX N/A
- Industry
- BSY Retail: Computer Software & Peripheral Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSY Technology
- NBIX Health Care
- Exchange
- BSY Nasdaq
- NBIX Nasdaq
- Market Cap
- BSY 15.4B
- NBIX 14.4B
- IPO Year
- BSY 2020
- NBIX 1996
- Fundamental
- Price
- BSY $49.66
- NBIX $142.11
- Analyst Decision
- BSY Buy
- NBIX Strong Buy
- Analyst Count
- BSY 11
- NBIX 18
- Target Price
- BSY $56.64
- NBIX $172.06
- AVG Volume (30 Days)
- BSY 1.6M
- NBIX 875.7K
- Earning Date
- BSY 11-05-2025
- NBIX 10-28-2025
- Dividend Yield
- BSY 0.56%
- NBIX N/A
- EPS Growth
- BSY N/A
- NBIX 12.44
- EPS
- BSY 0.78
- NBIX 4.19
- Revenue
- BSY $1,419,643,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- BSY $11.15
- NBIX $23.68
- Revenue Next Year
- BSY $10.37
- NBIX $18.02
- P/E Ratio
- BSY $64.27
- NBIX $33.87
- Revenue Growth
- BSY 10.45
- NBIX 19.61
- 52 Week Low
- BSY $36.51
- NBIX $84.23
- 52 Week High
- BSY $59.25
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- BSY 39.92
- NBIX 52.21
- Support Level
- BSY $50.06
- NBIX $133.62
- Resistance Level
- BSY $52.39
- NBIX $144.97
- Average True Range (ATR)
- BSY 0.94
- NBIX 4.05
- MACD
- BSY -0.11
- NBIX -0.16
- Stochastic Oscillator
- BSY 5.48
- NBIX 51.89
About BSY Bentley Systems Incorporated Class B
Bentley Systems is a software vendor that caters to engineers, architects, constructors, and geospatial professionals by enabling design, modeling, simulation, project management, and data management of infrastructure assets. The firm delivers solutions via the cloud, desktop, and hybrid environments. While Bentley is relatively small in comparison with peers like Autodesk, it shines in core specialty areas, like bridge or rail design, as opposed to being more broad-based in its applications. Bentley's largest end market is the public works and utilities sector, which represents approximately two thirds of revenue.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.